Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
Clinical trial NCT04584983 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04584983
- Sponsor
- The University of Texas Health Science Center, Houston
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-11
- Primary completion
- 2024-03-14
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.